Leukotriene Receptor Inhibitors

LTB₄

LTC₄/CysLT₂

LTD₄/CysLT₁

LTE₄

Leukotriene Receptor Inhibitors, Agonists & Antagonists

Product Name	LTB₄	LTC₄/CysLT₂	LTD₄/CysLT₁	LTE₄	Purity
MK-571 sodium			LTD₄, Ki: 0.22±0.15 nM (In guinea pig lung) LTD₄, Ki: 2.1±1.8 nM (In human lung) LTD₄, pA2: 10.5	LTE₄, pA2: 10.4	99.75%
Montelukast sodium			CysLT₁		99.84%
Zafirlukast			LTD₄		99.89%
Etalocib sodium	LTB₄
Montelukast			CysLT₁		99.94%
Pranlukast		LTC₄, Ki: 5640 nM	LTD₄, Ki: 0.99 nM	LTE₄, Ki: 0.63 nM	99.61%
MK-571			LTD₄, Ki: 0.22 nM (In guinea pig lung) LTD₄, Ki: 2.1 nM (In human lung) LTD₄, pA2: 10.5 (on guinea pig ileum)	LTE₄, pA2: 10.4 (on guinea pig ileum)	98.66%
CP-105696	LTB₄, IC₅₀: 8.42±0.26 nM				99.81%
Nedocromil		LTC₄			98.02%
Fiboflapon	LTB₄, IC₅₀: 76 nM				99.50%
12S-HHT	BLT2				≥99.0%
BIIL-260 hydrochloride	LTB₄, Ki: 1.7 nM				99.90%
LY255283	LTB₄, IC₅₀: ~100 nM (LTB₄ binds to guinea pig lung membranes)				98.52%
Pranlukast hemihydrate		LTC₄, Ki: 5640 nM	LTD₄, Ki: 0.99 nM	LTE₄, Ki: 0.63 nM	99.28%
Gemilukast		CysLT₂, IC₅₀: 25 nM	CysLT₁, IC₅₀: 1.7 nM		99.50%
Veliflapon	LTB₄	LTC₄			99.48%
Etalocib	LTB₄				98.74%
(S)-Verapamil hydrochloride		LTC₄			98.30%
LY223982	LTB₄, IC₅₀: 13.2 nM				99.67%
5-O-Demethylnobiletin		LTC₄, IC₅₀: 0.35 μM			99.91%
Quinotolast sodium		LTC₄			98.38%
HAMI 3379		CysLT₂			99.76%
Darbufelone mesylate	LTB₄				99.65%
Fiboflapon sodium	LTB₄, IC₅₀: 76 nM				99.46%
Amelubant	LTB₄, Ki: 221 nM (in vital human granulocytes) LTB₄, Ki: 230 nM (in cell membranes)				99.11%
20-Carboxy-Leukotriene B4	BLT1				≥98.0%
Tipelukast			LTD₄, pA2: 6.41 (In guinea-pigs)	LTE₄, pA2: 6.45 (In guinea-pigs)	99.40%
Nedocromil sodium		LTC₄
KP496			LTD₄		99.79%
CAY10789			CysLT₁, IC₅₀: 2.8 ± 0.3 μM		99.84%
(Rac)-HAMI 3379		CysLT₂
AS-35		LTC₄, IC₅₀: 8 nM (In isolated guinea pig ileum)	LTD₄, IC₅₀: 4 nM (In isolated guinea pig ileum)	LTE₄, IC₅₀: 3 nM (In isolated guinea pig ileum)
Montelukast dicyclohexylamine			CysLT₁
CP-96021			LTD₄, Ki: 34±5 nM		98.04%
BLT2 probe 1	BLT2
LTB4 antagonist 1	LTB₄
SB-209247	LTB₄, Ki: 0.78 nM
DW-1350	LTB₄
5-LOX-IN-6	LTB₄
CP-195543	LTB₄
BLT2 antagonist-1	BLT2, IC₅₀: 224 nM
14,15-Dehydro Leukotriene B4	BLT1, Ki: 27 nM BLT2, Ki: 473 nM
Triptinin B			LTD₄
BAY-u 9773		LTC₄	LTD₄
Iralukast			CysLT₁, pKi: 7.8
LTB4 antagonist 2	LTB₄, IC₅₀: 439 nM
Ablukast			LTD₄		99.36%
Quininib		CysLT₂, IC₅₀: 52 μM	CysLT₁, IC₅₀: 1.2 μM
CAY10583	BLT2
CP-96021 hydrochloride		LTC₄, Ki: 34 nM
LM-1484		LTC₄	CysLT₁
RS-601			LTD₄
CysLT1 receptor antagonist-1			CysLT₁, IC₅₀: 3.9 μM
CP-96486			LTD₄, Ki: 20 nM
ONO4057	LTB₄, IC₅₀: 0.7 μM
LTD4 antagonist 1			LTD₄, Ki: 0.57 nM
LY210073	LTB₄, IC₅₀: 6.2 nM
CI-949		LTC₄, IC₅₀: 0.5 μM	LTD₄, IC₅₀: 0.5 μM
YM158 free base			LTD₄, pA2: 8.87
Bunaprolast	LTB₄
LTB4-IN-1	LTB₄, IC₅₀: 70 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.